The nematode Caernorhabditis elegans is used in Dr. Julián Cerón’s laboratory as a model for several diseases. The group has recently published two articles, in Genetics and in Nature medicine.
Read moreBy activating the PPAR receptors, ABTL0812 induces over-expression of TRIB3 protein, which binds to the Akt oncogene and inhibits the Akt/mTOR axis.
Read moreSe trata de un estudio a nivel nacional junto al Instituto de Salud Carlos III de Madrid sobre la presencia de metales en los enfermos. La Universidad de Huelva analizará 10.000 muestras de uñas y 3...
Read moreOne of the biggest challenges in the development of chemotherapeutic agents is to obtain highly selective species that selectively attack tumoral cells while showing low cytotoxicity against normal ce...
Read moreWIN will address the most critical question facing clinical cancer research: Why the improvement of survival still remains limited for most cancer patients?
Read moreNew research led by the University of Oviedo has identified the protein AIRAPL as a new hematological tumor suppressor. The work published in ‘Nature Medicine' provides new biological keys concernin...
Read moreA study published in the prestigious journal Nature Communications –led by the Centro Nacional de Analisis Genómico (CNAG-CRG), located at the Barcelona Science Park (PCB), and the German Cancer R...
Read moreThe gene identified (referred ADAR1) regulates the level of mutations in RNA, and it is a publisher gene. People with an excess of this gene have an imbalance in the composition of this molecule just ...
Read moreEste trabajo representa un importante avance para conocer mejor el intrincado mecanismo de regulación de senescencia y abre nuevas vías para investigar la conexión de senescencia con otros procesos...
Read moreThe designed compounds have particularly high therapeutic effects on tumour cells of breast and colon and can be the basis for the development of oncological drugs of low toxicity and high selectivity...
Read moreActive Motif es una empresa especializada en el desarrollo de herramientas innovadoras para la investigación en el campo de la epigenética y la regulación génica que forma parte del catálogo de c...
Read moreMyriad is actively collaborating with leading pharmaceutical companies to develop Tumor BRACAnalysis CDx as a companion diagnostic for use with certain PARP inhibitors, platinum-based drugs and other ...
Read more